Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)

A Multi-center Study on Iridocorneal Endothelial (ICE) Syndrome in China

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03270761

Enrollment

Registered

2017-09-01

Start date

2017-09-10

Completion date

2019-12-31

Last updated

2021-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

This is a multi-center study to report the demographic profile, clinical features, and management in patients with Iridocorneal endothelial (ICE) syndrome in China.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of ICE syndrome; * Those willing to sign the informed consent.

Exclusion criteria

* Patients who don't sign the informed consent or abide by the study procedure.

Design outcomes

Primary

Measure	Time frame	Description
Management in patients with Iridocorneal endothelial (ICE) syndrome	through study completion, an average of 1 year	Record the number of medication treating corneal edema or glaucoma, and surgery (anti-glaucoma surgery, keratoplasty)

Secondary

Measure	Time frame	Description
Demographic profile of patients	1 day	Range of age, gender

Countries

China

Outcome results